halothane has been researched along with Cerebral Pseudosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stevens, WC | 1 |
| Eger, EI | 1 |
| White, A | 1 |
| Halsey, MJ | 1 |
| Munger, W | 1 |
| Gibbons, RD | 1 |
| Dolan, W | 1 |
| Shargel, R | 1 |
| Read, AE | 1 |
1 review available for halothane and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Immunological liver disease.
Topics: Acidosis, Renal Tubular; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cholangiograph | 1973 |
1 other study available for halothane and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals.
Topics: Anesthesia, Inhalation; Anesthetics; Animals; Body Weight; Chemical and Drug Induced Liver Injury; D | 1975 |